These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10623767)

  • 41. Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: effects on viral replication.
    Bollinger RC; Quinn TC; Liu AY; Stanhope PE; Hammond SA; Viveen R; Clements ML; Siliciano RF
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1067-77. PubMed ID: 7906131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection.
    Chen G; Shankar P; Lange C; Valdez H; Skolnik PR; Wu L; Manjunath N; Lieberman J
    Blood; 2001 Jul; 98(1):156-64. PubMed ID: 11418475
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential in vitro activation of CD4+CD8- and CD8+CD4- herpes simplex virus-specific human cytotoxic T cells.
    Yasukawa M; Inatsuki A; Kobayashi Y
    J Immunol; 1989 Sep; 143(6):2051-7. PubMed ID: 2476493
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytotoxic T-lymphocytes that kill autologous CD4+ lymphocytes are associated with CD4+ lymphocyte depletion in HIV-1 infection.
    Grant MD; Smail FM; Rosenthal KL
    J Acquir Immune Defic Syndr (1988); 1994 Jun; 7(6):571-9. PubMed ID: 7909845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
    Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
    J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Virus-specific cytotoxic T lymphocyte responses in patients infected with the human immunodeficiency virus, HIV-1.
    Rivière Y
    Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():45-8. PubMed ID: 7950861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activated peripheral CD8 lymphocytes express CD4 in vivo and are targets for infection by human immunodeficiency virus type 1.
    Imlach S; McBreen S; Shirafuji T; Leen C; Bell JE; Simmonds P
    J Virol; 2001 Dec; 75(23):11555-64. PubMed ID: 11689637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased CXCR3+ CD8 T cells in advanced human immunodeficiency virus infection suggest that a homing defect contributes to cytotoxic T-lymphocyte dysfunction.
    Brainard DM; Tager AM; Misdraji J; Frahm N; Lichterfeld M; Draenert R; Brander C; Walker BD; Luster AD
    J Virol; 2007 Aug; 81(16):8439-50. PubMed ID: 17553894
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Viral-specific cytotoxic T lymphocytes lyse human immunodeficiency virus-infected primary T lymphocytes by the granule exocytosis pathway.
    Shankar P; Xu Z; Lieberman J
    Blood; 1999 Nov; 94(9):3084-93. PubMed ID: 10556193
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection.
    Price DA; O'callaghan CA; Whelan JA; Easterbrook PJ; Phillips RE
    Clin Sci (Lond); 1999 Dec; 97(6):707-18. PubMed ID: 10585898
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of human immunodeficiency virus type 1 replication in primary CD4(+) T lymphocytes, monocytes, and dendritic cells by cytotoxic T lymphocytes.
    Severino ME; Sipsas NV; Nguyen PT; Kalams SA; Walker BD; Johnson RP; Yang OO
    J Virol; 2000 Jul; 74(14):6695-9. PubMed ID: 10864688
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Partial restoration of cytokine profile despite reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients during highly active antiretroviral treatment.
    Alfonzo M; Blanc D; Troadec C; Eliaszewicz M; Gónzalez G; Scott-Algara D
    Scand J Immunol; 2003 Apr; 57(4):375-83. PubMed ID: 12662301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load.
    Oxenius A; Price DA; Dawson SJ; Günthard HF; Fischer M; Perrin L; Ramirez E; Fagard C; Hirschel B; Scullard G; Weber JN; McLean AR; Phillips RE;
    AIDS; 2002 Nov; 16(17):2317-22. PubMed ID: 12441804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lack of correlation between phenotype activation markers of CD8 lymphocytes and cytotoxic T lymphocyte (CTL) function in HIV-1 infection: evidence for rescue with rIL-2.
    Chia WK; Nisbet-Brown E; Li X; Salit I; Joshi S; Read SE
    Viral Immunol; 1994; 7(2):81-95. PubMed ID: 7848511
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function.
    Kostense S; Ogg GS; Manting EH; Gillespie G; Joling J; Vandenberghe K; Veenhof EZ; van Baarle D; Jurriaans S; Klein MR; Miedema F
    Eur J Immunol; 2001 Mar; 31(3):677-86. PubMed ID: 11241270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys.
    Kuroda MJ; Schmitz JE; Charini WA; Nickerson CE; Lord CI; Forman MA; Letvin NL
    J Virol; 1999 Feb; 73(2):1573-9. PubMed ID: 9882363
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
    Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
    J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytomegalovirus (CMV) Epitope-Specific CD4
    Abana CO; Pilkinton MA; Gaudieri S; Chopra A; McDonnell WJ; Wanjalla C; Barnett L; Gangula R; Hager C; Jung DK; Engelhardt BG; Jagasia MH; Klenerman P; Phillips EJ; Koelle DM; Kalams SA; Mallal SA
    J Immunol; 2017 Nov; 199(9):3187-3201. PubMed ID: 28972094
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gag-positive reservoir cells are susceptible to HIV-specific cytotoxic T lymphocyte mediated clearance in vitro and can be detected in vivo [corrected].
    Graf EH; Pace MJ; Peterson BA; Lynch LJ; Chukwulebe SB; Mexas AM; Shaheen F; Martin JN; Deeks SG; Connors M; Migueles SA; O'Doherty U
    PLoS One; 2013; 8(8):e71879. PubMed ID: 23951263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.